Ajanta Pharma Limited has informed the Exchange about Schedule of meet
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the stock exchanges that its Board will meet and announce Q1 FY2026 (April–June 2025) unaudited financial results on 28th July 2025. Following the Board meeting, the company will host an earnings conference call at 4:00 PM IST on the same day, where the leadership team will discuss the financial performance and answer investor questions. The call will be accessible to investors in India, the US, UK, Hong Kong, and Singapore through dedicated dial-in numbers and a Diamond Pass registration link. A transcript and audio playback of the call will be made available on the company's website (www.ajantapharma.com) shortly after the event.
This is a routine advance notice of the upcoming quarterly results and investor call, so no immediate impact on the stock price is expected. Investors and analysts should watch the 28th July 2025 results and management commentary closely for cues on revenue growth, margins, and outlook, which could drive the next move in the stock.